Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Fetzima (Levomilnacipran) – Treatment for Major Depressive Disorder (MDD)

Drug Name (Brand / Generic)

Fetzima / levomilnacipran

Company / Licensee

Pierre Fabre Laboratories / Forest Laboratories

Therapy Class

Antidepressant

Product Description

Serotonin and norepinephrine reuptake inhibitor (SNRI)

Market Sector

CNS

Development Status

Approved in the US
Expand

Go Top